Document Detail


Sideroblastic anaemia and leukaemia in multiple myeloma.
MedLine Citation:
PMID:  105698     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Two patients with IgA myeloma and one patient with kappa light chain disease developed sideroblastic anaemia from two to four years after the initial diagnosis. All had previously received radiotherapy and chemotherapy (melphalan and prednisone). In two patients the myeloma was quiescent when the sideroblastic change occurred. Leukaemia occurred in two patients two and seven months respectively after the diagnosis of sideroblastic anaemia was made. In one of them, the myeloma became active again at the same time. The development of sideroblastic anaemia may be a pre-leukaemic event and may be recognised by the appearance of a dimorphic blood film.
Authors:
K P Phadke; Y L Kwan; S G Young
Related Documents :
7066208 - Erythropoiesis in the anaemia of rheumatoid arthritis.
18324878 - Anticancer therapy in patients with porphyrias: evidence today.
20509758 - Serum prohepcidin level in myelodysplasia.
4026178 - Anaemia in primary hyperparathyroidism--fantasy or reality.
23653268 - Development of contrast-induced nephropathy in subarachnoid hemorrhage: a single center...
24563868 - Determinants of noninvasive ventilation outcomes during an episode of acute hypercapnic...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Australian and New Zealand journal of medicine     Volume:  8     ISSN:  0004-8291     ISO Abbreviation:  Aust N Z J Med     Publication Date:  1978 Oct 
Date Detail:
Created Date:  1979-04-26     Completed Date:  1979-04-26     Revised Date:  2005-11-17    
Medline Journal Info:
Nlm Unique ID:  1264322     Medline TA:  Aust N Z J Med     Country:  AUSTRALIA    
Other Details:
Languages:  eng     Pagination:  539-43     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anemia, Sideroblastic / etiology*
Female
Humans
Immunoglobulin A
Immunoglobulin kappa-Chains
Leukemia / etiology*
Male
Melphalan / adverse effects,  therapeutic use
Middle Aged
Multiple Myeloma / complications*,  immunology,  therapy
Prednisone / adverse effects,  therapeutic use
Preleukemia
Chemical
Reg. No./Substance:
0/Immunoglobulin A; 0/Immunoglobulin kappa-Chains; 148-82-3/Melphalan; 53-03-2/Prednisone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A longitudinal study of the effectiveness of self applied 10 per cent stannous fluoride paste for se...
Next Document:  Brucella cultures typed by the Who Brucellosis Centre at the Commonwealth Serum Laboratories, Melbou...